secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2023-03-07T23:59:59+00:00
Accession:  0000950170-23-006453
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta stockholders re-elect directors, approve equity plan amendment and say-on-pay
--------------------------------------------------------------------------------

- Re-elected Bruce L.A. Carter and Jay R. Luly as Class I directors with 14.3M and 16.7M votes for.
- Approved amendment to 2019 Equity Incentive Plan to increase authorized shares by 975,000.
- Advisory say-on-pay vote approved with 16.2M votes for versus 1.4M against.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal year 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000095017023006453/0000950170-23-006453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000095017023006453/enta-20230302.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-006453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer